Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow Jrheum on BlueSky
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
Research ArticleArticle

A Delphi Exercise to Identify Characteristic Features of Gout — Opinions from Patients and Physicians, the First Stage in Developing New Classification Criteria

Rebecca L. Prowse, Nicola Dalbeth, Arthur Kavanaugh, Adewale O. Adebajo, Angelo L. Gaffo, Robert Terkeltaub, Brian F. Mandell, Bagus P.P. Suryana, Claudia Goldenstein-Schainberg, Cèsar Diaz-Torne, Dinesh Khanna, Frederic Lioté, Geraldine Mccarthy, Gail S. Kerr, Hisashi Yamanaka, Hein Janssens, Herbert F. Baraf, Jiunn-Horng Chen, Janitzia Vazquez-Mellado, Leslie R. Harrold, Lisa K. Stamp, Mart A. Van De Laar, Matthijs Janssen, Michael Doherty, Maarten Boers, N. Lawrence Edwards, Peter Gow, Peter Chapman, Puja Khanna, Philip S. Helliwell, Rebecca Grainger, H. Ralph Schumacher, Tuhina Neogi, Tim L. Jansen, Worawit Louthrenoo, Francisca Sivera and William J. Taylor
The Journal of Rheumatology April 2013, 40 (4) 498-505; DOI: https://doi.org/10.3899/jrheum.121037
Rebecca L. Prowse
From the University of Otago, Dunedin, New Zealand; University of Auckland, Auckland, New Zealand; Veterans Affairs Healthcare System, University of California, San Diego, California, USA; University of Sheffield, Sheffield, UK; Veterans Affairs Medical Center and University of Alabama at Birmingham, Birmingham, Alabama, USA; CCF Lerner College of Medicine of Case Western Reserve University, The Cleveland Clinic, Cleveland, Ohio, USA; Brawijaya University and Dr. Saiful Anwar Hospital, Malang, Indonesia; Faculdade de Medicina da Universidade de São Paulo e Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil; Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; University of Michigan, Ann Arbor, Michigan, USA; University Paris Diderot, Sorbonne Paris Cité and Hôpital Lariboisière, Paris, France; University College Dublin, Dublin, Ireland; Veterans Affairs Medical Center, Georgetown and Howard Universities, Washington, DC, USA; Tokyo Women's Medical University, Tokyo, Japan; Department of Primary and Community Care, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands; The Center for Rheumatology and Bone Research, Arthritis and Rheumatism Associates, Wheaton, Maryland, USA; China Medical University, China Medical University Hospital, Taichung, Taiwan; Hospital General de Mexico, Mexico City, Mexico; University of Massachusetts Medical School, Worcester, Massachusetts, USA; University of Otago, Christchurch, New Zealand; Department of Rheumatology and Clinical Immunology, Medisch Spectrum Twente, Enschede, The Netherlands; Department of Rheumatology, Rijnstate, Arnhem, The Netherlands; University of Nottingham, Nottingham, UK; VU University Medical Center, Amsterdam, The Netherlands; University of Florida, Gainesville Florida, USA; Counties-Manukau District Health Board, Auckland, New Zealand; Canterbury District Health Board, Christchurch, New Zealand; University of Leeds, Leeds, UK; University of Otago, Wellington, New Zealand; University of Pennsylvania and Veterans Affairs Medical Center, Philadelphia, Pennsylvania, USA; Boston University School of Medicine, Boston, Massachusetts, USA; Department of Rheumatology, Radboud University Nijmegen Medisch Centrum, Nijmegen, The Netherlands; Chiang Mai University, Chiang Mai, Thailand; and Hospital General de Elda and Universidad Miguel Hernandez, Alicante, Spain.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicola Dalbeth
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arthur Kavanaugh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adewale O. Adebajo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Angelo L. Gaffo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert Terkeltaub
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brian F. Mandell
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bagus P.P. Suryana
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Claudia Goldenstein-Schainberg
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cèsar Diaz-Torne
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dinesh Khanna
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frederic Lioté
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Geraldine Mccarthy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gail S. Kerr
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hisashi Yamanaka
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hein Janssens
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Herbert F. Baraf
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jiunn-Horng Chen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Janitzia Vazquez-Mellado
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leslie R. Harrold
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lisa K. Stamp
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mart A. Van De Laar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthijs Janssen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Doherty
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maarten Boers
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
N. Lawrence Edwards
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Gow
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Chapman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Puja Khanna
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Philip S. Helliwell
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rebecca Grainger
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
H. Ralph Schumacher
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tuhina Neogi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tim L. Jansen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Worawit Louthrenoo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Francisca Sivera
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
William J. Taylor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Will.taylor{at}otago.ac.nz
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
PreviousNext
Loading

Article Figures & Data

Figures

  • Tables
  • The overlap and differences among features highly rated (median 7-9) by physicians and patients. US: ultrasound; DECT: dual-energy computed tomography; CT: conventional computed tomography; MRI: magnetic resonance imaging; MSU: monosodium urate.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1

    The overlap and differences among features highly rated (median 7-9) by physicians and patients. US: ultrasound; DECT: dual-energy computed tomography; CT: conventional computed tomography; MRI: magnetic resonance imaging; MSU: monosodium urate.

Tables

  • Figures
    • View popup
    Table 1

    Final ratings following the second iteration of the physician survey.

    Survey ItemsMedian (30th to 70th percentile)†Disagreement Index††
    Items agreed by physicians to be discriminatory
     MSU crystals present in joint aspirate/tissue9 (9 to 9)0
     Tophi (especially in typical sites such as hands, helix of the ear, olecranon bursa, and Achilles tendon)9 (8 to 9)0.13
     MSU crystals still present in the joint fluid despite the patient being asymptomatic9 (7 to 9)0.29
     Radiographic erosions with sclerotic margins and overhanging cortical edges8 (8 to 8)0
     First metatarsophalangeal joint (podagra) involved at the very first episode8 (7 to 8)0.16
     Abrupt onset of an attack that peaks around 12–24 hours8 (7 to 8)0.16
     Conventional CT tophi (soft-tissue masses of intermediate density)8 (7 to 8)0.16
     Recurrent stereotypical episodes of attacks8 (7 to 8)0.16
     MRI tophi (low to intermediate signal intensity on T1-weighted images)8 (7 to 8)0.16
     MRI tophi (variable intensity on T2-weighted images)8 (7 to 8)0.16
     Dual-energy CT to detect urate deposits8 (7 to 8)0.16
     First metatarsophalangeal joint involved ever7.5 (7 to 8)0.16
     US double-contour sign (hyperechoic band on the surface of articular cartilage)7.5 (7 to 8)0.16
     Severe pain that is maximal within 4–12 hours7 (7 to 8)0.16
     US tophi (hyperechoic, heterogeneous lesion surrounded by an anechoic rim)7 (7 to 8)0.16
     Serum uric acid elevated during the intercritical period*7 (7 to 8)0.16
     Attacks are monoarthritic in the first few years and become oligoarthritic and polyarthritic over time*7 (7 to 8)0.16
     Between attacks, the patient appears well with no signs of pain or obvious inflammation7 (6 to 8)0.37
     Redness/erythema around the affected joint observed by the physician7 (6 to 8)0.37
     Marked joint tenderness — patient protects the affected joint from use or from being knocked7 (6 to 7)0.22
     Monoarticular joint involvement in acute attacks7 (6 to 7)0.22
     Resolution of an attack within 7–14 days7 (6 to 7)0.22
     Raised serum urate level*7 (6 to 7)0.22
     Joints of the midfoot are affected, observed by the physician*7 (6 to 7)0.22
     Uric acid nephrolithiasis (kidney stones)7 (5.1 to 8)0.62
     US joint effusion (snowstorm appearance due to MSU crystals within the synovial fluid)7 (5 to 7)0.52
    Items agreed by physicians to be of uncertain discrimination
     Patient responds rapidly to low-dose colchicine treatment*6.5 (6 to 7)0.22
     Swelling resolves once symptoms subside, observed by the physician6.5 (5 to 7)0.52
     Serum uric acid elevated during acute attack of gout*6.5 (5 to 7)0.52
     Warmth of skin overlying affected joint, as observed by the physician*6 (6 to 7)0.22
     Onset of a gout attack is generally at night*6 (6 to 7)0.22
     MRI erosion (a sharply marginated bone lesion with cortical bone defect)*6 (6 to 7)0.22
     Conventional CT to detect urate deposits*6 (6 to 7)0.22
     Conventional CT to detect erosion*6 (6 to 7)0.22
     Swelling of associated bursa, observed by the physician6 (5.3 to 7)0.42
     Other joints affected that are typical of gout (midfoot, ankle, knee)6 (5.1 to 7)0.48
     Swelling in the joint, as observed by the physician*6 (5 to 7)0.52
     Redness/erythema around the affected joint, as observed by the patient*6 (5 to 7)0.52
     Precipitation of an episode by purine-containing food (such as seafood or red meat), alcohol, dehydration, or drugs (such as diuretics)6 (5 to 7)0.52
     Swelling resolves once symptoms subside, as observed by the patient*6 (5 to 7)0.52
     Chronic uric acid nephropathy*6 (5 to 7)0.52
     If the patient is female she is postmenopausal*6 (5 to 7)0.52
     Patient is unable to wear shoes*6 (5 to 7)0.52
     Skin peels/scales over the affected area as acute attack is resolving*6 (5 to 7)0.52
     Previous diagnosis of gout made by another physician*6 (5 to 7)0.52
     Other joints are affected that are typical of gout such as ankle and knee, observed by the physician*6 (5 to 6)0.32
     Patient has a history of chronic, heavy alcohol intake*6 (5 to 6)0.32
     Patient is taking medication such as diuretics*6 (5 to 6)0.32
     Patient is a male*6 (5 to 6)0.32
     Patient is an organ graft recipient*6 (4.3 to 7)0.81
     Synovial fluid cultures of affected joint are negative for organisms (to exclude septic arthritis)*6 (4.3 to 6)0.66
     Family history of gout*5.5 (5 to 6)0.32
     Redness of skin with skip area (suggestive of gouty cellulitis), which can eliminate cellulitis (redness of skin without skip area)*5.5 (5 to 6)0.32
     US erosion (break in the cortical contour)*5 (5 to 6)0.32
     US tendon pathology (includes tenosynovitis, tendinosis, and intratendinous tophi)*5 (5 to 6)0.32
     Reduced renal uric acid excretion*5 (4.3 to 6)0.66
     Swelling of associated bursa, as observed by the patient*5 (4 to 6)0.85
     Warmth of skin overlying the affected joint, as observed by the patient*5 (4 to 6)0.85
     Asymmetric joint involvement, as observed by the physician*5 (4 to 6)0.85
     Patient has a high purine diet (i.e., consumes large amounts of red meat and shellfish)*5 (4 to 6)0.85
     Patient is obese*5 (4 to 6)0.85
     Patient has previously had a cardiovascular disease such as heart failure or myocardial infarction*5 (4 to 6)0.85
     US power Doppler signal (PWD 2–3) in monoarthritis*5 (4 to 6)0.85
     Elevated neutrophils within the synovial fluid*5 (4 to 5)0.32
     Patient is top aged (40–50 years old)*5 (4 to 5)0.32
     Swelling in the joint, as observed by the patient*5 (3 to 6)0.97
     Elevated leukocytes within the synovial fluid*5 (3 to 5)0.52
     Inflammatory cells present in fluid aspirated from affected joint*5 (3 to 5)0.52
     Pain is relieved by joint aspiration*4.5 (3 to 5)0.52
     Patient also suffers from diabetes*4 (4 to 5)0.32
     Elevated serum C-reactive protein*4 (3.3 to 5)0.47
     Pain prevents walking*4 (3 to 5.7)0.81
     Asymmetric joint involvement, as observed by the patient*4 (3 to 5)0.52
     Acute uric acid nephropathy*4 (3 to 5)0.52
     Elevated erythrocyte sedimentation rate*4 (3 to 5)0.52
     Aspiration of previously affected joint shows elevated leukocyte count in joint fluid*4 (3 to 4)0.22
     MRI synovitis (an area of synovial compartment is enhanced with contrast, and is thicker than the width of normal synovium)*4 (3 to 4)0.22
     US calcium deposits (focal hyperechoic deposits within hyaline cartilage)*4 (3 to 4)0.22
    Items agreed by physicians to be not discriminatory
     Polyarticular disease, as observed by the physician*3.5 (3 to 4)0.22
     Fewer than 5 joints affected3 (3 to 5)0.52
     Fever3 (3 to 5)0.52
     Polyarticular disease, observed by the patient3 (3 to 4)0.22
     Patient has hypertension*3 (3 to 4)0.22
     Functional disability (difficulty with daily activities)3 (2 to 5)0.65
     Loss of function of the joint (due to loss of joint motion)3 (2 to 4.9)0.62
     MRI cartilage pathology (focal and diffuse narrowing)3 (2 to 4.9)0.62
     Calcium nephrolithiasis3 (2 to 4)0.37
     Radiographic joint space abnormalities (includes widening, narrowing, and ankylosis)3 (2 to 4)0.37
     Patient complains of flu-like symptoms3 (1.1 to 4)0.48
     Malaise3 (1.1 to 4)0.48
     Elevated platelet count2 (1.1 to 4)0.48
     Early morning stiffness lasting > 30 minutes2 (1 to 2.9)0.27
     Spinal involvement2 (1 to 2)0.13
    • ↵* Rating from final iteration.

    • ↵† Values of 1–3.5 indicate the item was considered not discriminatory for gout, 4–6.5 as uncertain, and 7–9 as discriminatory for gout.

    • ↵†† Disagreement index > 1 indicates disagreement18. US: ultrasound; CR: conventional radiology; CT: computed tomography; MRI: magnetic resonance imaging; MSU: monosodium urate.

    • View popup
    Table 2

    Final ratings following the third iteration of the patient survey.

    Survey ItemsMedian (30th to 70th percentile) Rating†Disagreement Index††
    Items agreed by patients as being discriminatory
     Blood test shows an increase in uric acid in the blood9 (9 to 9)0
     During an attack of gout the pain is so bad you find it hard to walk9 (9 to 9)0
     During an attack of gout you cannot use the affected joint9 (8.6 to 9)0.05
     During an attack of gout the pain is so bad it interrupts your sleep9 (8.2 to 9)0.1
     During an attack of gout the joint is so sensitive you cannot even sleep with a sheet touching the affected area9 (7.2 to 9)0.26
     Medication such as indomethacin, allopurinol, or colchicine keeps the gout attacks at bay9 (6.6 to 9)0.37
     The pain is of a throbbing type9 (5.6 to 9)0.59
     Presence of crystals from joint fluid under a microscope9 (5.6 to 9)0.59
     An attack of gout often occurs after eating seafood/shellfish*8 (7 to 9)0.29
     Onset of an attack is sudden8 (6.6 to 9)0.37
     The big toe is affected8 (6 to 9)0.49
     The affected joint is hot8 (5.6 to 9)0.59
     The affected joint is red8 (5.6 to 9)0.59
     Tophi (lumps) are present in areas such as the elbows, fingers, and toes8 (5 to 9)0.75
     The pain is annoying8 (4.2 to 8.4)0.98
     A flare-up of an attack of gout responds rapidly to medication such as prednisone or naproxen7 (7 to 7.8)0.13
     The affected area is very sensitive to touch7 (6.2 to 9)0.45
     The affected joint is swollen7 (6 to 9)0.49
     An attack of gout often occurs after consuming alcohol*7 (6 to 8.6)0.45
     Severe, sharp pain in the affected joint7 (5.6 to 9)0.59
     The affected joint is enlarged7 (5.6 to 8)0.48
     If you injure an area that has been affected by gout, it takes longer to heal than one that has not been affected by gout*7 (5 to 9)0.75
     Only one foot is usually affected at a time7 (5 to 9)0.75
     The pain is still present even when the affected joint is not being moved/used7 (5 to 9)0.75
     There is a burning feeling in the affected area7 (4.6 to 8.4)0.83
    Items agreed to be uncertain
     An attack of gout often occurs after eating red meat*6 (5.4 to 7.2)0.42
     An increase in blood pressure may be observed*5 (5 to 7.8)0.63
     Other members of your family have/have had gout*5 (5 to 6.6)0.45
     The duration of an attack of gout is relatively short (1–2 days)*5 (4.4 to 6.6)0.71
    Items agreed to be not discriminatory
     The affected joints appear deformed/have changed shape*3 (2.4 to 5)0.6
     The elbows are affected*3 (1.8 to 5)0.67
     The ball of the foot is affected*3 (1.4 to 5.6)0.91
     The fingers are affected*3 (1.4 to 4.2)0.5
     An attack of gout often occurs after eating asparagus3 (1 to 5)0.75
     The knees are affected*3 (1 to 4.2)0.54
     The pain is always present in the hands — even in the absence of an attack of gout1 (1 to 5)0.75
    Items for which there was disagreement
     The pain may produce depression*7 (4 to 9)1.09
     The joints in the top of the foot are affected*4 (2.4 to 6.2)1.12
     White lumps are observed on the fingers*5 (3.8 to 8)1.14
     The area around the affected joint is swollen*8 (3.8 to 9)1.17
     The pain is worse when you move the affected joint*5 (3.4 to 8.6)1.35
     When these lumps are lanced they release a white substance*1 (1 to 6.8)1.45
     Friction/rubbing makes the affected joint more painful*5 (1.8 to 6.8)1.47
     The attack resolves quickly*5 (2.4 to 7)1.64
     The affected joint is stiff*3 (1.8 to 7.6)2.07
     The ankles are affected*5 (2.4 to 7.6)2.21
    • ↵* Item re-rated during the third iteration.

    • ↵† Values of 1–3.5 indicate the item was considered not discriminatory for gout, 4–6.5 as uncertain, and 7–9 as discriminatory for gout.

    • ↵†† Disagreement index > 1 indicates disagreement18.

PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 40, Issue 4
1 Apr 2013
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
A Delphi Exercise to Identify Characteristic Features of Gout — Opinions from Patients and Physicians, the First Stage in Developing New Classification Criteria
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
A Delphi Exercise to Identify Characteristic Features of Gout — Opinions from Patients and Physicians, the First Stage in Developing New Classification Criteria
Rebecca L. Prowse, Nicola Dalbeth, Arthur Kavanaugh, Adewale O. Adebajo, Angelo L. Gaffo, Robert Terkeltaub, Brian F. Mandell, Bagus P.P. Suryana, Claudia Goldenstein-Schainberg, Cèsar Diaz-Torne, Dinesh Khanna, Frederic Lioté, Geraldine Mccarthy, Gail S. Kerr, Hisashi Yamanaka, Hein Janssens, Herbert F. Baraf, Jiunn-Horng Chen, Janitzia Vazquez-Mellado, Leslie R. Harrold, Lisa K. Stamp, Mart A. Van De Laar, Matthijs Janssen, Michael Doherty, Maarten Boers, N. Lawrence Edwards, Peter Gow, Peter Chapman, Puja Khanna, Philip S. Helliwell, Rebecca Grainger, H. Ralph Schumacher, Tuhina Neogi, Tim L. Jansen, Worawit Louthrenoo, Francisca Sivera, William J. Taylor
The Journal of Rheumatology Apr 2013, 40 (4) 498-505; DOI: 10.3899/jrheum.121037

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
A Delphi Exercise to Identify Characteristic Features of Gout — Opinions from Patients and Physicians, the First Stage in Developing New Classification Criteria
Rebecca L. Prowse, Nicola Dalbeth, Arthur Kavanaugh, Adewale O. Adebajo, Angelo L. Gaffo, Robert Terkeltaub, Brian F. Mandell, Bagus P.P. Suryana, Claudia Goldenstein-Schainberg, Cèsar Diaz-Torne, Dinesh Khanna, Frederic Lioté, Geraldine Mccarthy, Gail S. Kerr, Hisashi Yamanaka, Hein Janssens, Herbert F. Baraf, Jiunn-Horng Chen, Janitzia Vazquez-Mellado, Leslie R. Harrold, Lisa K. Stamp, Mart A. Van De Laar, Matthijs Janssen, Michael Doherty, Maarten Boers, N. Lawrence Edwards, Peter Gow, Peter Chapman, Puja Khanna, Philip S. Helliwell, Rebecca Grainger, H. Ralph Schumacher, Tuhina Neogi, Tim L. Jansen, Worawit Louthrenoo, Francisca Sivera, William J. Taylor
The Journal of Rheumatology Apr 2013, 40 (4) 498-505; DOI: 10.3899/jrheum.121037
del.icio.us logo Twitter logo Facebook logo  logo Mendeley logo
  • Tweet Widget
  •  logo
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • ACKNOWLEDGMENT
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • References
  • PDF

Keywords

GOUT
CLASSIFICATION
CRITERIA
PATIENTS
PHYSICIANS

Related Articles

Cited By...

More in this TOC Section

  • Multitarget Therapy With Rituximab Plus Mycophenolate Mofetil Versus Rituximab Monotherapy in Systemic Sclerosis–Associated Interstitial Lung Disease
  • Clinical Features and a Nomogram for Predicting Clinical Response in Juvenile Dermatomyositis–Associated Interstitial Lung Disease
  • Who Achieves Minimal and Very Low Disease Activity in Psoriatic Arthritis? An Analysis of the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry
Show more Article

Similar Articles

Keywords

  • gout
  • classification
  • criteria
  • PATIENTS
  • PHYSICIANS

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2025 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire